Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
10 participants
INTERVENTIONAL
2019-03-08
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postprandial Glycemic Response in Adults With Type 2 Diabetes
NCT05154045
Evaluation of Glycemic Response in Individuals With Type 2 Diabetes
NCT05165693
Glycemic Response in Adults With Type 2 Diabetes
NCT05166200
Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes
NCT00622960
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
NCT00753181
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Almond Butter
Participants will consume one ounce per day (\~32 g) of almond butter as an evening snack (i.e., after dinner and before sleep).
Almond Butter
Natural almond butter
No-snack Control
Participants will consume nothing besides water after dinner/bed sleep.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Almond Butter
Natural almond butter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not on insulin therapy
* On stable does of oral antihyperglycemic agent (no dose change for 6 months)
* Currently monitoring blood glucose at home via glucometer
* Willing and able to adhere to study protocol
Exclusion Criteria
* Women who are pregnant, breastfeeding, or have been pregnant within the last 6 months or breastfeeding within the last 6 weeks
* Individuals who smoke or use tobacco products
* Use of insulin therapy or sulfonylurea medications
* Allergy to any tree nut
* Liver or kidney disease
* Allergy to Dexcom CGM adhesive
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Penny M Kris-Etherton, PhD, RDN
Role: PRINCIPAL_INVESTIGATOR
Penn State
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn State
University Park, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKE AlmondButter
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.